Movalis (Meloxicam)

Meloxicam works by reversibly inhibiting cyclooxygenase enzymes, especially COX‑2, which are essential for prostaglandin production. Lower prostaglandin levels lead to reduced inflammation, pain, and fever, providing symptomatic relief in musculoskeletal disorders.

The appropriate dose of Movalis is determined by the prescribing healthcare professional based on the individual’s medical condition, age, renal and hepatic function, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Meloxicam is generally avoided during pregnancy, especially in the third trimester, because of potential risks to the fetus. It is also excreted in breast milk, so breastfeeding mothers should consult their physician before using Movalis to weigh benefits against possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with non‑selective NSAIDs, meloxicam has a higher selectivity for COX‑2, which may result in a slightly lower incidence of gastrointestinal side effects. However, it still carries cardiovascular and renal risks similar to other NSAIDs, so individual patient factors guide the choice of therapy.

Movalis should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Movalis is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce gastrointestinal discomfort. The exact timing and frequency are set by the prescribing clinician.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe liver injury, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice symptoms such as black stools, chest pain, or widespread rash.

Movalis is contraindicated in patients with known hypersensitivity to meloxicam or other oxicam NSAIDs, those with active gastrointestinal bleeding or ulceration, severe heart failure, and in the third trimester of pregnancy. Caution is also advised for individuals with significant renal or hepatic impairment.